When: Sustained above $500 for 4-6 weeks with 50 SMA holding on retests and macro clearing

Then: Move to Overweight only after confirmed regime, not single-day breakout

HOLD

• September 30 high of $515.42 vs Bollinger upper band of $516.26 represents normal post-rally consolidation, not a failed breakout; 22.5% gain in nine sessions is healthy uptrend behavior
• AMAT fundamentals: 41% ROE, $9.2 billion liquid assets, $2.3 billion quarterly free cash flow; not a name to sell at current levels
• Fresh catalysts: $5 billion EPIC Center partnership with KIOXIA and $5 billion India research park commitment are multi-year revenue drivers
• Working capital concerns (inventory $6.5 billion, DSO 79.2 days) reflect supply chain building ahead of shipments in stretching lead time environment, not warning signs
• Revenue acceleration from $6.8B to $7.0B to $7.9B to $9.1B sequentially validates inventory build; backlog indicators surging across equipment space
• Operating margins of 33.7% expanded for four consecutive quarters; structural mix shift toward advanced packaging, gate-all-around, HBM tools supports durability
• 97% Polymarket Fed cut probability is already priced; actual forward risk is 10-year stability, not the known-known scenario
• Stock at ~$518 is already 30% below $739.67 52-week high; multiple compression risk largely realized in price already
• 50-SMA at $487.82 and 10-EMA at $481.63 define structural invalidation; $480 close is the line for reassessment, not current levels
• SELL plan entry at $520 above current price creates contingent execution risk in 1.6 beta, 40-point ATR tape; trim may never execute in volatile moves
• Stop at $480 represents only 6% trailing exposure (3.8% market-equivalent with beta 1.6), appropriate for confirmed uptrend reclaiming 50-SMA with MACD bullish crossover
• Conservative principle: let confirmed uptrends continue until they break; do not preemptively fade based on macro narratives

→ vs aggressive: The 'failed bounce' narrative is pattern-matching that doesn't apply; a 22.5% vertical move pausing at resistance with a close at $511 near the day's low is statistically normal consolidation, not bearish

→ vs aggressive: The 'asymmetric trade' framing is flawed; selling into strength on ambiguous working capital data and priced macro consensus is not asymmetry, it's being less right while capping upside participation

→ vs aggressive: Working capital metrics (inventory, DSO) are being misused; in a stretching lead time environment with above-one book-to-bill, building inventory ahead of shipments is sound supply chain management, not a warning

→ vs aggressive: The 97% Fed cut probability is already priced; calling it a forward catalyst misreads what the market will react to versus what is already consensus

→ vs aggressive: The valuation 'cyclically implausible' argument ignores four consecutive quarters of margin expansion and structural business mix shift toward higher-margin advanced packaging and AI memory tools

→ vs aggressive: The SELL plan's entry at $520 above current price means contingent execution may fail in a 1.6 beta, 40-point ATR environment; trim never executes and full exposure remains into a resolved move

→ vs aggressive: The 6% trailing stop at $480 is not 'tight risk control' as characterized; it's generous downside exposure for a confirmed uptrend with fresh MACD bullish crossover and 50-SMA reclaim

Trim 15-20% of current allocation at market; keep core position with stop at $480; re-add trimmed portion if stock breaks above $516 with volume confirmation

• Measured 15-20% trim recommended versus aggressive's 30-40%
• Execute at market now rather than waiting for $520-$530 zone due to unreliable contingent execution in volatile tape
• Stop at structural invalidation around $480; trim more aggressively on way down toward $460 if broken
• Re-entry trigger: break above $516 on closing basis with volume and follow-through
• MACD crossover printed two days ago confirms momentum, not exhaustion
• Aggressive analyst cherry-picking bearish price action read while ignoring bullish momentum signal
• Conservative analyst conflating franchise quality (41% ROE, net cash, $2.3B quarterly FCF) with price discipline
• September 30 candle is healthy pause in uptrend, not textbook failed bounce
• Working capital ambiguity should default toward smaller positions, not unchanged ones, for tactical allocation in beta 1.6 name
• Macro inputs causing compression (10-year at multi-decade highs, Fed on hold) are intensifying, not resolved
• Richard Ross at Evercore ISI: sustained 10-year above 5% challenges bull case
• Compression trade not complete because rates trade not complete

→ vs aggressive: Execution plan requires selling into $520-$530 zone but stock at $511; with beta 1.6 and 40-point ATR, may never see those levels if 10-year spikes to 5.10% on hot CPI; contingent execution creates worst of both worlds

→ vs aggressive: Calling September 30 candle a 'failed bounce' is overconfident pattern-matching; stock ran 22.5% in nine sessions and closed up, doing what healthy uptrends do

→ vs aggressive: Cannot cherry-pick bearish read on price action and bullish read on momentum simultaneously; MACD crossover confirms continuation, not exhaustion

→ vs conservative: Using franchise quality to argue against any proactive risk management conflates two separate questions; question is whether current risk-reward is attractive for marginal dollar on 2-4 quarter horizon

→ vs conservative: 24% drawdown absorbing multiple compression is hindsight bias; macro inputs causing compression (10-year at multi-decade highs) are intensifying, not resolved

→ vs conservative: Conservative response to ambiguous signals is to size accordingly, not ignore them; ambiguous signals should default toward smaller positions for tactical allocation in beta 1.6 name